PLSE Insider Trading
Insider Ownership Percentage: 71.50%
Insider Buying (Last 12 Months): $2,007,434.98
Insider Selling (Last 12 Months): $871,000.00
Pulse Biosciences Insider Trading History Chart
This chart shows the insider buying and selling history at Pulse Biosciences by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Pulse Biosciences Share Price & Price History
Current Price: $14.20
Price Change: ▼ Price Decrease of -0.28 (-1.93%)
As of 04/9/2025 01:22 PM ET
Pulse Biosciences Insider Trading History
Pulse Biosciences Institutional Trading History
Data available starting January 2016
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Read More on Pulse Biosciences
Today's Range
Now: $14.20
52 Week Range
Now: $14.20
Volume
32,651 shs
Average Volume
197,014 shs
Market Capitalization
$955.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.87
Who are the company insiders with the largest holdings of Pulse Biosciences?
Who are the major institutional investors of Pulse Biosciences?
Which major investors are buying Pulse Biosciences stock?
Within the last quarter, PLSE stock was acquired by institutional investors including:
- GAMMA Investing LLC
- Rhumbline Advisers
In the last year, these company insiders have bought Pulse Biosciences stock:
- Robert W Duggan (Director)
- Mitchell E Levinson (Insider)
- Burke Thomas Barrett (CEO)
- Kevin Patrick Danahy (CEO)
Learn More investors buying Pulse Biosciences stock.